Quantity of suitable sufferers: CDEC mentioned the uncertainty in the number of sufferers with moderately serious to critical hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some individuals that are classified as possessing gentle or average sickness could have a extreme bleeding phenotype, https://hemgenix59374.acidblog.net/66926740/about-hemgenix